HUISHENG BIOPHARMACEUTICAL
Huisheng Bio is a diabetes and complication treatment solution provider. The company was founded in 2019 and is headquartered in Jilin, China.
HUISHENG BIOPHARMACEUTICAL
Industry:
Biopharma Biotechnology Health Care Medical Pharmaceutical
Founded:
2019-01-01
Address:
Jilin, Jilin, China
Country:
China
Website Url:
http://www.huishengpharm.com
Total Employee:
51+
Status:
Active
Total Funding:
500 M CNY
Technology used in webpage:
SPF Alibaba HiChina DNS Tencent QQ Mail
Investors List
Ginkgo Capital
Ginkgo Capital investment in Series A - Huisheng Biopharmaceutical
Grand Flight Investment
Grand Flight Investment investment in Series A - Huisheng Biopharmaceutical
Chinalife Tech-Innovation Fund
Chinalife Tech-Innovation Fund investment in Series A - Huisheng Biopharmaceutical
Official Site Inspections
http://www.huishengpharm.com Semrush global rank: 8.73 M Semrush visits lastest month: 261
- Host name: 116.255.245.171
- IP address: 116.255.245.171
- Location: China
- Latitude: 39.9289
- Longitude: 116.3883
- Timezone: Asia/Shanghai
More informations about "Huisheng Biopharmaceutical"
Huisheng Biopharmaceutical - Crunchbase Company …
Huisheng Bio is a diabetes and complication treatment solution provider. The company was founded in 2019 and is headquartered in Jilin, China.See details»
惠升简介-惠升生物 - huishengpharm.com
惠升生物制药股份有限公司是四环医药控股集团根据战略发展规划设立的专注于糖尿病及并发症治疗领域，涵盖生物药及化药产品，拥有完整产品管线的综合性制药企业，2014年即在四环集 …See details»
Hangzhou Huisheng Biotech Pharmaceutical Co., Ltd.--Hangzhou …
News. Dynamic real-time update, keep abreast of the latest trends. 2024.10.8 Milan CPHI. Release time: 2024-10-11. Celebrating HS team Milan CPHI's peSee details»
联系我们-惠升生物 - huishengpharm.com
惠升生物制药股份有限公司 公司总部. 地址： 吉林省梅河口市康美大道666号 电话： 0435-5199089 邮箱： [email protected] 北京惠升生物科技有限公司 生物创新药研发 …See details»
惠升生物制药股份有限公司 - 爱企查
简介： 1、基本情况 惠升生物制药股份有限公司是一家瞪羚企业(2024)、小微企业，该公司成立于2019年05月17日，位于吉林省梅河口市爱民东大街1088号，目前处于开业状态，经营范围包 …See details»
Jilin Huisheng Biopharmaceutical Co., Ltd. | VentureRadar
Website: http://www.huishengpharm.com/ Offers comprehensive diabetes and complications treatment solutions, focusing on strategic transformation and commitment to ...See details»
Company Profile - hsbiopharm.com
Contact Us. ADD: Room 403,Jinsha Century Building,Qiantang New Area,Hangzhou City,Zhejiang Province,China.310018 Tel: 0086-571-86877572/ 88958509See details»
Jilin Huisheng Biopharmaceutical Co., Ltd.: Drug pipelines, Patents ...
Explore Jilin Huisheng Biopharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, .See details»
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
了解Jilin Huisheng Biological Pharmaceutical Co., Ltd. (惠升生物制药股份有限公司)公司的药物管线，治疗领域，技术平台，以及它的19项临床试验, 1篇新闻，疾病领域:内分泌与代谢疾病， …See details»
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
Explore Jilin Huisheng Biological Pharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 19 clinical trials, Disease Domain:Endocrinology and Metabolic Disease, …See details»
惠升生物与华东医药宣布就1类新药惠优静在中国大陆的商业化权 …
惠升动态. 2024年9月20日，惠升生物制药股份有限公司（简称“惠升生物”）与华东医药股份有限公司（简称“华东医药”）全资子公司华东医药（杭州）有限公司就其已上市创新产品惠优静（脯 …See details»
Huisheng Pharma Co Ltd - Company Profile and News
Company profile page for Huisheng Pharma Co Ltd including stock price, company news, executives, board members, and contact informationSee details»
惠升生物 - 公司详情 - 融资历史 - innoHere英诺嘿呀
惠升生物是一家糖尿病及并发症治疗方案提供商，专注糖尿病及并发症治疗领域，致力于为患者提供全程、全方位治疗方案，是拥有完整糖尿病及并发症产品管线的生物制药企业。目前糖尿病 …See details»
【融资】惠升生物制药（HuiSheng Pharm）完成5.8亿元A+轮融资 …
⌈ByDrug医药新闻摘要⌋ 2023-01-04 17:29，微创投：吉林惠升生物制药有限公司（惠升生物，HuishengPharm）已成功完成由江苏国寿疌泉股权投资中心(有限合伙)、天津远翼永宣企业 …See details»
Chinese Self-Developed IDegAsp Debuts! Huisheng Pharm Strives …
Aug 12, 2024 Seeing a set of data intuitively, the World Health Organization reported that 425 million adults worldwide suffer from diabetes, and about 1.6 million people die each year as a …See details»
营销中心-惠升生物 - huishengpharm.com
直营产品：加格列净、德谷系列、glp-1等 分销产品：多种口服降糖药、多种并发症药物. 过往业绩证实此独特的营销模式非常成功，兼具高效产出及成本效率；建立专门、规模化的直销队伍推 …See details»
Huisheng Biopharmaceutical - Golden
Huisheng Biopharmaceutical is a Jilin-based company founded in 2019. Overview Structured Data Issues Contributors Activity. ContentsSee details»
Jilin Huisheng Biological Pharmaceutical Co., Ltd.
Explore Jilin Huisheng Biological Pharmaceutical Co., Ltd. with its drug pipeline, therapeutic area, technology platform, 18 clinical trials, Disease Domain:Endocrinology and Metabolic Disease, …See details»
星火燎原争朝夕 行稳致远赢未来||惠升生物2022年工作总结暨2023 …
Jan 11, 2023 岁聿云暮，一元复始 新的画卷伴随秒针转动过零点而徐徐展开。 我们携手为充满机遇和挑战的 2022年画上了圆满的句号， 奋楫同向齐心踏上了2023年的全新征程。-惠升动态See details»
重塑胰岛素市场 国产首个德谷门冬双胰岛素注射液横空出世 惠升 …
Aug 21, 2024 惠升动态. 2024年7月30日，惠升生物研发的德谷门冬双胰岛素注射液（商品名：惠优加®）获国家药监局批准上市，标志着国产德谷门冬双胰岛素注射液生物类似药的首度亮相。See details»